Kisunla for Alzheimer’s Now 40% Safer
July 10, 2025
Why Did Europe Finally Choose Lecanemab for Alzheimer’s?
Europe originally said Lecanemab (Brand-name Leqembi) was too risky to approve. Now they are recommending marketing it. Why the change of heart? (Video)
Source:
Related:
Ensuring Lecanemab Reaches Those Who Need It
June 5, 2025
Best Time to Stop Medicine for Dementia
May 29, 2025
Lecanemab’s Rare and Manageable Side Effects
May 23, 2025
How Many People Take Leqembi?
May 5, 2025
Email me when people comment
Login
0 Comments
Edited by:
Peter Berger
With experience in dementia caregiving, public education, and Alzheimer’s-focused writing—and a professional research background shaped in what many consider one of the world’s top laboratories—I work to make complex findings clear, practical, and genuinely helpful for families and professionals providing care.
Welcome. About this Site.
This site was inspired by my Mom’s autoimmune dementia.
It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. it has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.
The site is dedicated to all those preserving the dignity of the community of people living with dementia.
Peter Berger, Editor
Share this page To
Dementia Books & Videos on Amazon:
More From Alzheimer's Weekly
Prevention
NRTIs Have Potential to Prevent a Million Cases of Alzheimer’s Every Year
The drugs, called NRTIs, have the potential to prevent a million cases of Alzheimer’s every year, the researchers believe.
No Comments
Exercise
“Prescribing” Exercise Fights Alzheimer’s
TED VIDEO + FREE BOOK + 13 EASY WORKOUTS: PEOPLE WITH MEMORY ISSUES EXPERIENCED slower degeneration in a brain region crucial for memory when exercising
No Comments
Prevention
New Burst of Interest: Is Alzheimer’s an Infection?
There’s a new wave of Alzheimer’s interest rising in the infectious diseases community. Perhaps it’s because the cause-and-cure for Alzheimer’s remain mysteries, despite decades and
No Comments
Lewy Body
Cognitive Boost for Dementia with Lewy Bodies
GOOD NEWS: Donepezil (Aricept®), approved for Alzheimer’s, also passed a long-term trial for Dementia with Lewy Bodies (DLB). Get the details on the medicine’s positive
6 Comments
Share to Facebook
Twitter
LinkedIn
Welcome. About this Site.
This site was inspired by my Mom’s autoimmune dementia.
It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. it has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.
The site is dedicated to all those preserving the dignity of the community of people living with dementia.
Peter Berger, Editor
Visit Alzheimer's Weekly On